On-demand virtual event
Biological & Medicinal Chemistry
As part of ACS’s celebration of NCW (October 15-21), Dr. Jayanta Haldar (Jawaharlal Nehru Centre for Advanced Scientific Research) will discuss the growing threat posed by drug-resistant bacteria through his work with Vancomycin, a blockbuster antibiotic that has been lifesaving against multidrug-resistant Gram-positive infections. The increased prevalence of vancomycin-resistant bacteria and the inherent challenges of complicated infections highlight the urgent need to develop credible alternatives to Vancomycin. Dr. Haldar will describe his work towards designing multi-target acting next-generation analogues which possess additional modes of action and have demonstrated superior efficacy in tackling vancomycin resistance in Gram-positive as well as Gram-negative bacteria, including multidrug-resistant strains.
Then, Dr. Karmella A. Haynes (Emory University School of Medicine) will discuss her lab’s research into chromatin, the DNA-protein structure that packages eukaryotic genes, and their work to investigate and design chromatin-based systems for controlling gene expression in cancer. Her lab’s approach, which they call “macrogenomic engineering,” uses histone-binding protein motifs to build fusion transcription factors that co-regulate groups of genes based on their chromatin features. In her talk, Dr. Haynes will discuss how these systems could be useful in activating anti-cancer gene expression to empower the body to intrinsically fight off cancer.
What You Will Learn
Meet The Experts
Jayanta Haldar, Editor-in-Chief, ACS Infectious Diseases
Karmella A. Haynes, Assistant Professor, Wallace H. Coulter Department of Biomedical Engineering, Emory University
Catherine Goodman, Senior Associate Publisher, American Chemical Society
Keep learning. Excel in your career.
Choose from more than 200 courses in seven different categories, taught by experts in the chemistry community, online and in person.